Interest Rate Worries Trap Bulls and Gain Momentum
Numbers are pointing in the same direction, and it is the wrong one for stocks.
You've reached your free article limit
You've read 0 of 1 free Pro articles.
We had ugly action Wednesday with broad selling and, for once, no rotation into big-caps to relieve the sting. Within the S&P 500, only energy was positive, climbing 1% as oil advanced. Small-caps drove the decline, with the Russell 2000 down 1.8%, the Nasdaq down 1.1%, and the S&P and Dow down 0.8% and 0.7%, respectively.
After a day like that, the tendency is for some positive rotation to shore up the indexes, but early action is negative again Thursday. It appears that no immediate relief is coming from the rotational action that has bailed this market out all year.
Yields Are the Whole Story
Higher government bond yields are hitting stocks worldwide. The 10-year Treasury closed near 5.11% Wednesday, its highest level since July 2007, and it is edging up toward 5.14% Thursday morning. Borrowing costs are surging across Asia and Europe as well, so this is a global move, not a domestic one.
The bond selloff has fundamental driving forces behind it. This is not just sentiment at work. The S&P Global PMI came in strong Wednesday, which fueled rate-hike expectations. The odds of an October hike jumped from 55% Tuesday to closer to 70%.
Fed Governor Michael Barr said he expects further rate increases. A 5-year Treasury auction was met with weak demand, producing the highest yield in two decades. When the auction is weak, it means buyers are not interested even at 5%, which is a clear sign of more pressure on the longer-duration bonds.
The 2-year Treasury closed at 4.89%, the highest since May 2024. The 30-year hit 5.40%, the highest since 2004. Oil is not helping, with Brent right around $100. Every one of those numbers points in the same direction, and it is the wrong one for stocks.
Why Rate-Sensitive Groups Got Hit Hardest
The selling was not evenly distributed, and the pattern tells you what is driving it. The groups that got hit hardest are the ones most dependent on cheap money.
Small-caps led the decline, and that is no surprise. Smaller companies do not have the cash reserves the mega-caps do, so they rely more on borrowing, and higher rates hit them directly. The Russell 2000 underperformance is the rate story showing up where it always shows up first.
Biotech was the worst group of all, for a sharper version of the same reason. Many biotech companies need substantial outside funding to advance their drug programs, and higher interest rates make that funding far more expensive. When rates spike, the market marks down the companies that depend most on outside capital, and early-stage biotech sits at the very top of that list.
One thing that is different about the cycle this time is the mega-caps. The mega-caps have always been the safe haven when rates rise, because they generate enormous cash and do not need to borrow. This time they do not have that cushion. They are spending money like drunken sailors on the SI/AI buildout, and that capex has to be financed. For the first time, the biggest companies in the market carry real exposure to rising rates, which removes the usual place investors hide when the rate story turns ugly.
The weakness across all of these groups is not about the businesses themselves. It is about the cost of the money they need. If rates stabilize, the hardest-hit names can bounce hard, since nothing changed at the company level. Until then, they stay under pressure for a reason that has little to do with the health of their businesses.
The Trap Is Still Working
The Meta (META) surge earlier this week created a short-term move that sucked in breakout buyers, and they are now trapped. If there is not a quick recovery, those trapped positions become a source of more selling, because people who bought the high and are now underwater eventually give up and add to the pressure.
The big question is whether the downside picks up momentum from here. We have the combination that produces pressure. There is negative seasonality, interest rate worries, and no clear positive catalyst.
The one potential positive Thursday is the Trump-Xi summit, and there is already a piece of good news. Treasury Secretary Bessent said Wednesday night the U.S. and China will extend their trade truce until mid-January, avoiding the higher tariffs that were set for November. Whether that is enough to offset the interest rate concerns, we will have to wait and see.
Game Plan
I have been anticipating this kind of action, which is why I have written so much about staying patient, holding cash, and waiting for better entry points. I will consider some small incremental buying if the downside gets more severe, but I do not plan to be aggressive until there is support and some chart improvement.
One of the biggest mistakes traders make is buying too big and too fast into a decline, hoping to catch a bounce. The better approach is to avoid the game of predicting the exact low and to buy charts only after they show signs of stabilizing. A falling stock with no base under it can fall a lot further than looks possible, and the buyer who goes all in at the first attractive price is usually the one still adding when it breaks.
I would rather be a little late buying a stock that has proven it can hold support than early into one that is still searching for a floor. The market is testing my discipline, but I’m confident that patience is going to produce some positive outcomes as we move past the midterm elections.
At the time of publication, Rev Shark had no positions in any securities mentioned.
